282 related articles for article (PubMed ID: 19900520)
41. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
[TBL] [Abstract][Full Text] [Related]
42. Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine.
Hagenaars N; Verheul RJ; Mooren I; de Jong PH; Mastrobattista E; Glansbeek HL; Heldens JG; van den Bosch H; Hennink WE; Jiskoot W
J Control Release; 2009 Dec; 140(2):126-33. PubMed ID: 19712713
[TBL] [Abstract][Full Text] [Related]
43. Histological evaluation of buccal penetration enhancement properties of chitosan and trimethyl chitosan.
Sandri G; Poggi P; Bonferoni MC; Rossi S; Ferrari F; Caramella C
J Pharm Pharmacol; 2006 Oct; 58(10):1327-36. PubMed ID: 17034655
[TBL] [Abstract][Full Text] [Related]
44. Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses.
Al-Ghananeem AM; Saeed H; Florence R; Yokel RA; Malkawi AH
J Drug Target; 2010 Jun; 18(5):381-8. PubMed ID: 20001275
[TBL] [Abstract][Full Text] [Related]
45. The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs.
Trapani A; Sitterberg J; Bakowsky U; Kissel T
Int J Pharm; 2009 Jun; 375(1-2):97-106. PubMed ID: 19481695
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
47. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
Mukherjee S; Ray S; Thakur RS
Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
[TBL] [Abstract][Full Text] [Related]
48. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
Shinde UA; Joshi PN; Jain DD; Singh K
Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
[TBL] [Abstract][Full Text] [Related]
49. Controlled release study of 5-fluorouracil-loaded chitosan/polyethylene glycol microparticles.
Lin CC; Fu CH
Drug Deliv; 2009 Jul; 16(5):274-9. PubMed ID: 19538009
[TBL] [Abstract][Full Text] [Related]
50. Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination.
Verheul RJ; Slütter B; Bal SM; Bouwstra JA; Jiskoot W; Hennink WE
J Control Release; 2011 Nov; 156(1):46-52. PubMed ID: 21784113
[TBL] [Abstract][Full Text] [Related]
51. Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP/nanoparticles formulated with IL-12.
Xu Q; Guo L; Gu X; Zhang B; Hu X; Zhang J; Chen J; Wang Y; Chen C; Gao B; Kuang Y; Wang S
Biomaterials; 2012 May; 33(15):3909-18. PubMed ID: 22374455
[TBL] [Abstract][Full Text] [Related]
52. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
53. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain.
Pillay S; Pillay V; Choonara YE; Naidoo D; Khan RA; du Toit LC; Ndesendo VM; Modi G; Danckwerts MP; Iyuke SE
Int J Pharm; 2009 Dec; 382(1-2):277-90. PubMed ID: 19703530
[TBL] [Abstract][Full Text] [Related]
54. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
Lin CC; Lin CW
Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
[TBL] [Abstract][Full Text] [Related]
55. Formulation of chitosan-TPP-pDNA nanocapsules for gene therapy applications.
Gaspar VM; Sousa F; Queiroz JA; Correia IJ
Nanotechnology; 2011 Jan; 22(1):015101. PubMed ID: 21135452
[TBL] [Abstract][Full Text] [Related]
56. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
[TBL] [Abstract][Full Text] [Related]
57. Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles.
Jintapattanakit A; Junyaprasert VB; Mao S; Sitterberg J; Bakowsky U; Kissel T
Int J Pharm; 2007 Sep; 342(1-2):240-9. PubMed ID: 17597316
[TBL] [Abstract][Full Text] [Related]
58. Thiolated trimethyl chitosan nanocomplexes as gene carriers with high in vitro and in vivo transfection efficiency.
Zhao X; Yin L; Ding J; Tang C; Gu S; Yin C; Mao Y
J Control Release; 2010 May; 144(1):46-54. PubMed ID: 20093155
[TBL] [Abstract][Full Text] [Related]
59. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
Liu J; Gong T; Wang C; Zhong Z; Zhang Z
Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
